What is WO2010/029082 (and how does it relate to alpelisib)?
WO2010/029082 is a patent publication that includes claims covering chemical matter and/or synthetic approaches that can be used in making compounds in the same chemical space as alpelisib. Novartis is the company associated with the alpelisib development program, and patent filings around alpelisib often show up in the WO family publications tied to that program.
Why do people search “WO2010 029082 alpelisib synthesis Novartis”?
Searchers typically want one of three things:
- The exact claims tied to alpelisib-like structures (what the patent protects).
- The disclosed synthetic steps (how the patent describes making the compound class).
- The assignment/ownership trail that links the patent to Novartis and the alpelisib product.
Those items are usually spread across different parts of the publication: the “Description” for synthesis examples and the “Claims” for what is legally protected.
How to verify whether a specific “alpelisib synthesis” appears in WO2010/029082
Because many patent publications disclose multiple related compounds and routes, the only reliable way is to check:
- The compound list and example numbers in the “Examples” section.
- Whether the named compound in the examples matches alpelisib’s structure (not just a close analogue).
- Whether the patent’s claims explicitly mention alpelisib (or a Markush-defined formula broad enough to cover it).
If you have the WO publication text (or a link/claim excerpt), I can help you pinpoint the exact steps and whether they map to alpelisib specifically.
Where DrugPatentWatch can help for Novartis/alpelisib patent tracing
If your goal is to connect WO2010/029082 to alpelisib’s patent landscape (and to see related filings, family members, and status indicators), DrugPatentWatch is a useful starting point for the alpelisib portfolio and related patent families: https://www.drugpatentwatch.com/ (search for “alpelisib”).
Next step: share the link or the claim/example number you’re looking at
To give a precise “synthesis of alpelisib” answer for WO2010/029082, I need at least one of:
- the WO publication link (WIPO/Google Patents/other), or
- the specific example number (e.g., “Example 7”), or
- the claim text you think corresponds to alpelisib.
That lets me verify whether the document discloses alpelisib itself versus a related compound, and summarize the relevant synthetic route passages.
Sources
- https://www.drugpatentwatch.com/